Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
CPE CONSULTANTS, LLC
 

Sodium-glucose co-transporter 2 inhibitors: safety considerations and clinical implications for healthcare providers


Fee

$0.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

 

 

 

Objectives

  • Recall fundamental nephron and anatomy and physiology
  • Describe clinical implications of associated with SGLT inhibitors
  • Discuss the key evidence behind clinical implications
  • Identify which patient populations would apply to these considerations

Speaker(s)/Author(s)

David Comshaw-Arnold
PharmD candidate

Gyen Musgrave
Pharm D. Candidate

Jason W. Guy, Pharm. D.
Assistant Professor of Pharmacy Practice, The University of Findlay College of Pharmacy

Activity Number

0864-0000-18-020-H01-P

Release Date: May 1, 2018
Credit Expiration Date: May 1, 2020